April 7, 2004 |
A federal appeals court upheld Genentech Inc.'s legal victory in a $1-billion patent battle with Bay Area biotechnology rival Chiron Corp., Genentech said Tuesday. In 2002, a federal jury unanimously decided Emeryville, Calif.-based Chiron had no claim to share any profit from Genentech's blockbuster breast cancer drug Herceptin. Chiron appealed the ruling.
January 19, 2006 |
Microsoft Corp. plans to ask for a new judge to preside over a federal patent trial in which it would try to avoid paying $521 million in damages. The U.S. Court of Appeals for the Federal Circuit, without comment, said Microsoft could appeal U.S. District Judge James B. Zagel's refusal to step down from the case that centers on whether the company's Internet Explorer browser infringes a patent.
September 8, 2005 |
A U.S. appeals court upheld a $164.2-million verdict against Tyco International Ltd.'s Nellcor unit in a lawsuit filed by rival Masimo Corp. over machines that measure the oxygen content in blood. The U.S. Court of Appeals for the Federal Circuit in Washington also said the trial judge should have ordered Nellcor to stop selling pulse oximetry machines and directed her to issue a ban on such sales. The suit is one of several between the two companies over oximetry machines.
September 20, 2007 |
Microsoft Corp. won its bid to have a patent-infringement lawsuit by creditors of defunct Internet service provider At Home Corp. thrown out. The U.S. Court of Appeals for the Federal Circuit ruled in Washington that a trust set up to pay At Home's creditors lacked authority to sue Microsoft over a patent they received to pay bankruptcy claims. The court ruled that U.S.
September 27, 2007 |
Verizon Communications Inc., the No. 2 U.S. phone company, won an appeals court ruling upholding most of a patent verdict over rival Vonage Holdings Corp., the second legal setback for Vonage in two days. The U.S. Court of Appeals for the Federal Circuit in Washington also upheld a court order barring Vonage's use of Verizon's inventions, including a way of connecting Internet calls to standard phone lines. The order blocking use of the inventions had been on hold pending the appeal.
October 16, 2007 |
A federal judge indicated Monday that he would reverse his decision to double a $19.6-million damage award for Broadcom Corp. in a patent dispute with rival chip maker Qualcomm Inc. because a legal standard had changed. U.S. District Judge James Selna in Santa Ana issued a tentative ruling in which he said an appeals court changed the law he had applied. Selna on Aug. 10 had doubled the award to $39.3 million because Qualcomm's patent infringement was found to be deliberate. On Aug. 20, the U.S.
CALIFORNIA | LOCAL
March 29, 2010 |
In his slate-blue suit and Republican-red tie, John Yoo stands out as discordantly formal among the denim- and turtleneck-clad faculty at Boalt Hall School of Law. Never mind how his politics play in what he derides as "the People's Republic of Berkeley." The former Bush administration lawyer who drafted what his critics call the "torture memos" is reviled by many in this liberal East Bay academic enclave, a feeling that is mutual though not, Yoo insists, wholly unpleasant. "I think of myself as being West Berlin during the Cold War, a shining beacon of capitalism and democracy surrounded by a sea of Marxism," Yoo observes, sipping iced tea in the faculty club lounge, a wan smile registering the discomfort of colleagues walking by en route to the bar. He sees his neighbors as the human figures of "a natural history museum of the 1960s," the Telegraph Avenue tableau of a graying, long-haired, pot-smoking counterculture stuck in the ideology's half-century-old heyday.
January 22, 2005 |
A U.S. appeals court Friday limited the ability of generic-drug companies to challenge patents in a ruling affecting Pfizer Inc.'s antidepressant Zoloft. Teva Pharmaceutical Industries Ltd. sought to challenge Pfizer's patent on a method of making Zoloft so that the Israeli company could begin selling a generic version when the patent protecting the chemical composition of the drug expired in 2006. The U.S.